Cytokinetics, Inc. (CYTK)
63.35
-0.62
(-0.97%)
USD |
NASDAQ |
May 01, 16:00
63.35
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics EPS Diluted (Quarterly) : -1.495 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.308 |
| Johnson & Johnson | 2.141 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Edgewise Therapeutics, Inc. | -0.4737 |
| Moderna, Inc. | -3.40 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -183.03M |
| Revenue (Quarterly) | 17.76M |
| Total Expenses (Quarterly) | 200.79M |
| Enterprise Value | 8.201B |
| Gross Profit Margin (Quarterly) | 83.89% |
| Profit Margin (Quarterly) | -1.03K% |
| Earnings Yield | -10.31% |
| Normalized Earnings Yield | -9.231 |